Why the study?
Do measurements of F1+2, TAT, and D-dimer accurately rule out postoperative DVT in patients undergoing total hip replacement under antithrombotic prophylaxis?
Do measurements of F1+2, TAT, and D-dimer accurately rule out postoperative DVT in patients undergoing total hip replacement under antithrombotic prophylaxis?
Measurements of F1+2, TAT, and D-dimer lack sufficient sensitivity and negative predictive value to safely rule out DVT in patients receiving antithrombotic prophylaxis after total hip replacement.
Answers are grounded in this paper and cite their sources.
F1+2 and D-dimer lack adequate sensitivity to exclude postoperative DVT; leaves open whether alternative markers improve rule-out accuracy under prophylaxis.
BACKGROUND: Measurements of prothrombin fragment 1+2 (F1+2), thrombin antithrombin III complexes (TAT) and D-dimer plasma levels have been proposed as non-invasive screening tests to exclude postoperative deep venous thrombosis (DVT). We investigated the diagnostic efficacy of these coagulation activation markers to rule out postoperative DVT in patients undergoing hip surgery under antithrombotic prophylaxis. METHODS: In this substudy of a randomized double-blind thrombosis prophylaxis trial comparing three doses of desirudin (10, 15 or 20 mg b.i.d.) with unfractionated heparin (5000 IU t.i.d.) we used ELISA procedures to measure F1+2, TAT and D-dimer in 159 patients undergoing total hip replacement at baseline (day 0) and on postoperative days 1, 3 and 6. Bilateral venography was performed in all cases 8-11 days after surgery. RESULTS: For the F1+2 assay sensitivity ranged from 73 to 83% in the three postoperative days investigated, and negative predictive value (NPV) from 68 to 74%. For TAT and D-dimer sensitivity ranged from 71 to 73% and from 71 to 83% and NPV from 61 to 65% and from 61 to 74% respectively. INTERPRETATION: In terms of sensitivity and NPV F1+2 and D-dimer are equivalent and are superior to TAT. However, their accuracy is too low to rule out the presence of DVT after hip surgery under antithrombotic prophylaxis.
No takes yet. Share an insight, caveat, or question.
Cofrancesco et al. (1998) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: